Showing results (21-30 of 711) with videos related to
Sort By:
Pageof 72
Clinical Pharmacology and Therapeutics|May 1, 1995
Deficient C-oxidation of nicotineN L Benowitz, P Jacob, D P SachsBiomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1989
Nicotine gum and theophylline metabolismN L Benowitz, B L Lee, P JacobAnnals of Internal Medicine|April 1, 1987
Cigarette abstinence, nicotine gum, and theophylline dispositionB L Lee, N L Benowitz, P JacobClinical Pharmacology and Therapeutics|October 1, 1986
Additive cardiovascular effects of nicotine and ethanolN L Benowitz, R T Jones, P JacobClinical Pharmacology and Therapeutics|April 1, 1987
Influence of tobacco abstinence on the disposition kinetics and effects of nicotineB L Lee, N L Benowitz, P JacobTherapeutic Drug Monitoring|March 5, 1998
Evaluation of pharmacokinetic methods used to estimate caffeine clearance and comparison with a Bayesian forecasting methodC P Denaro, P Jacob, N L BenowitzPharmacogenetics|June 1, 1996
CYP2D6 phenotype and the metabolism of nicotine and cotinineN L Benowitz, P Jacob, E Perez-StableEuropean Journal of Clinical Pharmacology|January 1, 1993
A clinical pharmacological study of subcutaneous nicotineJ Le Houezec, P Jacob, N L BenowitzJournal of Chromatography|September 29, 1989
Sulfonium salts as derivatizing agents. 2. Determination of theophylline in plasma by automated gas chromatographyB L Lee, P Jacob, N L BenowitzJournal of Medicinal Chemistry|July 1, 1990
Synthesis of (3'R,5'S)-trans-3'-hydroxycotinine, a major metabolite of nicotine. Metabolic formation of 3'-hydroxycotinine in humans is highly stereoselectiveP Jacob, A T Shulgin, N L BenowitzPageof 72